Apricus Biosciences (APRI)

3.24 +0.22  +7.28%  May 17, 8:00PM
Add to Watchlists Create an Alert

Apricus Biosciences Revenue TTM:

8.416M for Dec. 31, 2012
View Full Chart

Apricus Biosciences Revenue TTM Chart

    Apricus Biosciences Historical Revenue TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 8.416M
    Sept. 30, 2012 6.172M
    June 30, 2012 1.820M
    March 31, 2012 3.295M
    Dec. 31, 2011 4.101M
    Sept. 30, 2011 5.016M
    June 30, 2011 5.306M
    March 31, 2011 5.182M
    Dec. 31, 2010 5.041M
    Sept. 30, 2010 4.301M
    June 30, 2010 3.321M
    March 31, 2010 1.953M
    Dec. 31, 2009 2.974M
    Sept. 30, 2009 6.179M
    June 30, 2009 6.375M
    March 31, 2009 7.472M
    Dec. 31, 2008 5.958M
    Sept. 30, 2008 2.861M
    June 30, 2008 2.851M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Revenues (TTM)

    Definition: Revenues

    Learn More

    Get data for

    APRI Revenue TTM Benchmarks

    Companies
    Warner Chilcott 2.541B
    POZEN 5.349M
    Pernix Therapeutics 61.31M

    APRI Revenue TTM Rankings

    Overall 41st percentile
    4453 of 7593
    Sector 37th percentile
    409 of 650 in Healthcare
    Industry 41st percentile
    38 of 65 in Drug Manufacturers - Specialty & Generic

    APRI Revenue TTM Range, Past 5 Years

    Minimum 1.820M Jun 2012
    Maximum 8.416M Dec 2012
    Average 4.663M